Home tumors
 

Keywords :   


Tag: tumors

TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination with KEYTRUDA (pembrolizumab) in Solid Tumors

2015-04-20 14:00:00| Merck.com - Product News

Dateline City: MALVERN, Pa. & KENILWORTH, N.J. MALVERN, Pa. & KENILWORTH, N.J.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, and Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today they have entered into an oncology clinical study collaboration. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558orClaire Mulhearn, 908-236-1118orMerck Investor Relations:Justin Holko, 908-740-1879orTetraLogic Investor Relations:Pete A. Meyers, 610-889-9900, x103pete.meyers@tlog.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: with combination solid evaluation

 

The Wall Street Journal: Merck drug shrank tumors in some breast cancer patients in trial

2014-12-10 16:19:02| Biotech - Topix.net

A Merck & Co. drug shrank tumors in about 18.5% of women with an aggressive form of breast cancer in a small clinical trial, an early sign of the potential of immunotherapy to treat breast tumors.

Tags: street journal trial wall

 
 

Attacking Tumors With Miniaturized, High-Frequency Antennas

2014-11-13 03:56:14| rfglobalnet Home Page

A team at the University of Wisconsin has figured out a way to miniaturize tumor ablation antennas by delving deep into microwave physics. These smaller scale antennas could provide surgeons with treatment options previously unavailable.

Tags: tumors attacking antennas miniaturized

 

A Better Imager for Identifying Tumors

2014-06-19 06:00:00| Industrial Newsroom - All News for Today

Research published in The Optical Society’s journal Optics Letters details new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real-time in OR. Developed by team at the University of Arizona and Washington University in St. Louis, dual-mode imager combines near-infrared fluorescent imaging to detect marked cancer cells and visible light reflectance imaging to see contours of tissue itself—all in 25 mm ...This story is related to the following:Trade Associations

Tags: identifying tumors imager

 

FoundationOne Identifies Clinically Relevant Alterations In Adolescent and Young Adult Solid Tumors

2014-06-02 20:44:03| Logistics - Topix.net

These data will be presented today in an oral abstract session at the 2014 American Society of Clinical Oncology Annual Meeting, abstract number 110081.

Tags: young relevant adult solid

 

Sites : [1] [2] [3] [4] next »